MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202441063036 A) filed by Biophore India Pharmaceuticals Pvt. Ltd on August 21, 2024, for Solid Dosage Forms Of Tafamidis And Its Pharmaceutically Acceptable Salt Thereof.
Inventors include Manik Reddy Pullagurla; Srinivas Arutla; and Jagadeesh Babu Rangisetty.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: ABSTRACT “Solid dosage forms of tafamidis and its pharmaceutically acceptable salt thereof” The present disclosure provides a solid pharmaceutical composition comprising of 5 tafamidis, a solubilizer, and one or more pharmaceutically acceptable excipients; and process of making such compositions. The present disclosure also provides a solid pharmaceutical composition comprising of tafamidis indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.
Disclaimer: Curated by HT Syndication.
